Neurofeedback Research Library

This preliminary study investigated the feasibility and reliability of an EEG-based brain mapping system in children with cerebral palsy (CP). Researchers found excellent test-retest reliability when measuring brainwave activity during motor tasks and observed distinct differences in cortical activation patterns between children with CP and typically developing children. The findings suggest that EEG brain mapping may be a valuable tool for studying neuroplasticity, motor recovery, and neurofeedback-based rehabilitation in pediatric neurological populations.

This study explored shared brain connectivity and genetic patterns in children with autism and/or ADHD using functional MRI and gene expression analysis. Researchers found that autism symptom severity was linked to altered connectivity between major brain networks involved in attention, executive functioning, and self-referential processing. The findings also identified shared genetic pathways associated with neurodevelopment and neuron connectivity, highlighting overlapping biological mechanisms between autism and ADHD.

This article highlights emerging research connecting dementia risk to dysfunction in the brain’s glymphatic system — the network responsible for clearing metabolic waste from the brain during sleep. Using data from more than 44,000 individuals, researchers found that impaired cerebrospinal fluid (CSF) movement and reduced waste clearance were associated with a higher risk of developing dementia. The findings further support the connection between cardiovascular health, brain waste clearance, and neurodegenerative disease.

This article discusses the use of neurofeedback as a therapeutic approach for individuals with cerebral palsy (CP). Drawing from over 25 years of clinical experience, the author describes how EEG-guided, site-specific neurofeedback protocols may help improve motor function, reduce spasticity, and support neurological development in individuals with CP. The paper highlights the importance of individualized treatment based on brainwave activity and neurological presentation.

This article discusses how quantitative EEG (QEEG) may help differentiate Alzheimer’s disease from other common forms of dementia, including Lewy body dementia, Parkinson’s disease dementia, frontotemporal dementia, and vascular dementia.

This study explored the effects of quantitative EEG (qEEG)–guided neurofeedback training in 20 individuals with Alzheimer’s disease and vascular dementia. Researchers found significant improvements in cognitive function, attention, memory recall, and overall quality of life following personalized neurofeedback treatment. The findings suggest that qEEG-guided neurofeedback may help support cognitive performance and brain regulation in individuals experiencing dementia-related symptoms.

This 2024 systematic review looked at randomized controlled trials on EEG neurofeedback training in sport psychology. The authors found that neurofeedback may help improve athletic performance, including areas like shooting accuracy, golf putting, motor skills, focus, and mental-state regulation. They also noted that more standardized research methods are needed to better understand how neurofeedback impacts performance.

This 2009 review article provides an overview of neurofeedback, explaining how EEG-based feedback is used to help individuals learn to regulate brain activity through operant conditioning and neuroplasticity. The paper discusses the history, technology, and clinical applications of neurofeedback, including its use in attention disorders, anxiety, epilepsy, peak performance, and emotional regulation. It also highlights the growing body of research supporting neurofeedback as a non-invasive approach for improving self-regulation and brain function. ([en.wikipedia.org][1]) [1]: https://en.wikipedia.org/wiki/Neurofeedback?utm_source=chatgpt.com "Neurofeedback"

This 1991 clinical study explored how EEG biofeedback (neurofeedback) could influence performance in pre-elite archers. Researchers found that athletes who received the correct neurofeedback training showed significant improvements in archery performance, while incorrect feedback negatively impacted results. The study supports the idea that neurofeedback may help enhance focus, concentration, and performance by training more optimal brainwave activity patterns. ([pubmed.ncbi.nlm.nih.gov][1]) [1]: https://pubmed.ncbi.nlm.nih.gov/1997806/?utm_source=chatgpt.com "The influence of electrocortical biofeedback on ..."

This 2024 study examined the effects of neurofeedback training in children with ADHD and found that a 10-week intervention was associated with improvements in executive functioning, including attention, inhibitory control, and cognitive flexibility. The researchers suggest that neurofeedback may help support cognitive performance and self-regulation in children with ADHD by encouraging healthier brain activity patterns through EEG-based feedback training.

Children affected by autism spectrum disorder (ASD) often have impairment of social interaction and demonstrate difficulty with emotional communication, display of posture and facial expression, with recognized relationships between postural control mechanisms and cognitive functions. Beside standard biomedical interventions and psychopharmacological treatments, there is increasing interest in the use of alternative non-invasive treatments such as neurofeedback (NFB) that could potentially modulate brain activity resulting in behavioral modification.

Effects of neurofeedback treatment were investigated in children with autism spectrum disorders (ASD). Sixty percent of the participants in the treatment group successfully reducedexcessivethetapowerduringneurofeedbacktreatment.Reductionofthetapower was confirmed by pre- and post-QEEG measures. Parents of participants in the neurofeedback treatment group reported significant improvements in reciprocal social interactions and communication skills, relative to the parents of the control group. Setshifting skills improved following neurofeedback treatment relative to the control group. The reduction of theta power is assumed to reflect modulation of activity in the anterior cingulate cortex (ACC),whichisknowntobeinvolvedinsocialandexecutivedysfunctions in autism.

Seven autistic children diagnosed with autism spectrum disorders (ASD) received a neurofeedback treatment that aimed to improve their level of executive control. Neurofeedback successfully reduced children's heightened theta/beta ratio by inhibiting theta activation and enhancing beta activation over sessions. Following treatment, children's executive capacities were found to have improved greatly relative to pre-treatment assessment on a range of executive function tasks. Additional improvements were found in children's social, communicative and typical behavior, relative to a waiting list control group. These findings suggest a basic executive function impairment in ASD that can be alleviated through specific neurofeedback treatment. Possible neural mechanisms that may underlie neurofeedback mediated improvement in executive functioning in autistic children are discussed.

This peer-reviewed article explores the use of neurofeedback as a non-invasive method for helping individuals learn to regulate brain activity through real-time EEG feedback. The study discusses how neurofeedback may support improvements in attention, self-regulation, cognitive performance, and neurological functioning by encouraging healthier brainwave patterns. It also highlights the growing interest in neurofeedback as a complementary approach within mental health, performance optimization, and neurological rehabilitation research.

Adults with ADHD learned SCP self‑regulation with moderate–large within‑group symptom improvements and ERP changes. Supports feasibility and symptom reduction in adult ADHD.

Using rt‑fMRI neurofeedback, participants learned to up/down‑regulate rostral ACC activity with corresponding changes in perceived pain. Pioneering evidence that self‑modulation of pain networks can reduce pain intensity.

Controlled trial demonstrated that individualized upper‑alpha neurofeedback enhanced working‑memory performance in healthy adults. Findings support cognitive performance applications of neurofeedback.

Pilot trial showed both Z‑score SMR and individualized EEG‑guided neurofeedback improved sleep time and daytime functioning in chronic insomnia. Provides early support for SMR‑targeted protocols.

Adults with ADHD showed significant improvements on multiple symptom scales after SCP‑neurofeedback, with medium–large effects post‑treatment and at 6‑month follow‑up. Learners who mastered regulation had the largest long‑term gains.

RCT found neurofeedback reduced cortical hyperarousal and alleviated insomnia symptoms, with benefits alongside CBT‑I benchmarks. Supports neurofeedback as a viable non‑pharmacologic option for insomnia.

Systematic review concluded rt‑fMRI neurofeedback enables learned modulation of motor networks with associated functional gains post‑stroke. Supports further controlled trials.

First RCT of simultaneous EEG‑fMRI neurofeedback in stroke survivors showed greater upper‑limb motor gains versus motor imagery training. Indicates neurofeedback can augment stroke rehab outcomes.

Prospective RCT found rt‑fMRI neurofeedback produced greater reductions in tinnitus distress than cognitive‑behavioral therapy. Supports neurofeedback as a viable first‑line option in select patients.

Review concluded standard protocols (SMR, Theta/Beta, SCP) yield medium‑to‑large effects for ADHD with 32–47% response rates above sham/control. Positions NF as well‑established for ADHD.

Study reported stabilization of neurophysiological and psychological markers in migraineurs after neurofeedback. Suggested improvements in emotional/cognitive regulation linked to migraine control.

Single‑blind RCT showed >40% reduction on the Hamilton Depression scale after emotion‑network fMRI neurofeedback. Demonstrated specificity over a control region protocol.

rt‑fMRI neurofeedback produced symptom improvements comparable to CBT among patients declining medications. Supports neurofeedback as a credible non‑pharmacologic option.

Combined neurofeedback/biofeedback led to ≥50% migraine reduction in 70% of participants versus 50% with medication alone. Demonstrated robust effect sizes for headache reduction.

Randomized study found significant increase in total sleep time only in the neurofeedback group, with reduced sleep latency in both groups. Objective PSG measures supported benefit.

rt‑fMRI neurofeedback targeting emotion networks decreased PTSD symptoms and normalized large‑scale network connectivity. Demonstrated mechanistic and clinical benefits.

Meta‑analysis highlighted improvements in inattention with EEG‑neurofeedback in pediatric ADHD. Provides additional support for clinical relevance.

EEG neurofeedback significantly reduced PTSD symptoms compared with a waitlist control. Participants showed improved emotional regulation and arousal markers.

Single‑blind RCT showed reductions in inattention, impulsivity, and hyperactivity after neurofeedback training. Addressed design limitations of earlier studies.

Large multicenter RCT found SCP‑neurofeedback superior to semi‑active EMG feedback on parent‑rated ADHD outcomes. Supports feasibility and efficacy in routine care settings.

Across RCTs with follow‑up (2–12 months), neurofeedback effects on ADHD symptoms were durable. Findings support lasting benefits consistent with a learning‑based intervention.

Randomized, controlled trial in children/adolescents showed neurofeedback improved ADHD symptoms vs. treatment‑as‑usual. Self‑report follow‑ups confirmed functional gains.

Meta‑analysis reported large effects for inattention/impulsivity and medium effects for hyperactivity across controlled studies. Supported neurofeedback as an effective option for ADHD.

Follow‑up of the 2009 RCT found sustained benefits at six months post‑treatment. Effects remained superior to the active control condition.

Multisite RCT in children showed neurofeedback superior to computerized attention training on core ADHD symptoms. Demonstrated clinically meaningful improvements in attention and impulse control.

Meta‑analysis across PTSD neurofeedback studies showed clinically meaningful symptom reductions and larger effects at follow‑up, supporting durability of benefit despite study heterogeneity.

Randomized two-arm trial comparing Alpha–Theta vs SMR EEG‑neurofeedback in GAD found both protocols reduced state/trait anxiety and perceived stress, with SMR showing slightly faster state-anxiety relief; benefits maintained at 2‑month follow‑up.

Narrative review of EEG‑neurofeedback for anxiety disorders and PTSD finds positive clinical signals across protocols while noting heterogeneity and the need for more rigorous sham‑controlled designs.

EEG‑based neurofeedback combined with mindfulness reduced state and trait anxiety and produced measurable neural changes post‑treatment, indicating relief of anxiety‑related over‑arousal.